An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
Diabetes is the 4th most common disease affecting the world’s population. It is accompanied by many complications that deteriorate the quality of life. Painful diabetic neuropathy (PDN) is one of the debilitating consequences of diabetes that effects one-third of diabetic patients. Unfortunately, th...
Saved in:
Main Authors: | Zunaira Qureshi, Murtaza Najabat Ali, Minahil Khalid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/9989272 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possible erythropoietin pharmacotherapeutic targets on painful diabetic neuropathy in rats
by: SAMUEL SUAREZ-MENDEZ, et al.
Published: (2025-02-01) -
Pharmacotherapeutic Options for Managing Neuropathic Pain: A Systematic Review and Meta-Analysis
by: Giulia Di Stefano, et al.
Published: (2021-01-01) -
Review of NVP and HG and Early Pharmacotherapeutic Intervention
by: Shannon M. Clark, et al.
Published: (2012-01-01) -
A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers
by: Ghanshyam B. Dudhatra, et al.
Published: (2012-01-01) -
Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments
by: Mark Yorek, et al.
Published: (2018-01-01)